Axin1 is known to function as a tumor suppressor by scaffolding the β-catenin destruction complex to promote β-catenin degradation; therefore, sgAxin1 is expected to stabilize β-catenin and activate β-catenin signaling. Here, AXIN1 is linked to neoplasm.